E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
DAWN holding history
Day One Biopharmaceuticals, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings
- Shares (Q2 2025)
- 10,988
- Value
- $71.4K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 10,988 | $71.4K | <0.1% | −148−1.3% | Reduced | Holders |
| Q1 2025 | 11,136 | $88.3K | <0.1% | −140−1.2% | Reduced | Holders |
| Q4 2024 | 11,276 | $142.9K | <0.1% | +11,276 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −12,618−100.0% | Sold out | Holders |
| Q4 2023 | 12,618 | $184.2K | <0.1% | +442+3.6% | Added | Holders |
| Q3 2023 | 12,176 | $149.0K | <0.1% | −3,465−22.2% | Reduced | Holders |
| Q2 2023 | 15,641 | $187.0K | <0.1% | +4,774+43.9% | Added | Holders |
| Q1 2023 | 10,867 | $145.0K | <0.1% | +103+1.0% | Added | Holders |
| Q4 2022 | 10,764 | $232.0K | <0.1% | +10,764 | New | Holders |